CompoAtlas

NOCTRIM LP

Food supplement declared in France, declaration No 2024-7-37, decision dated 1 July 2024

NOCTRIM LP is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
BIOCYTE
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
1 gélule
Directions for use
1 gélule par jour, avec un grand verre d’eau.
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes
Objectives stated by the manufacturer (these are not authorised claims)
Sommeil

Declaration 143312, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Valeriana officinalis L.RacineExtrait sec hydroalcoolique120 mg
Papaver rhoeas L.PétalesExtrait sec aqueux112 mg

Other active ingredients

NamePer day
Inulinenot declared
Mélatoninenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Oxyde de magnésiumMagnésium250 mg300 mg
Carbonate de magnésiumMagnésium250 mg300 mg
Bisglycinate de magnésiumMagnésium250 mg300 mg
Chlorhydrate de pyridoxineVitamine B612 mg2 mg

Additives

E464, E322, E460, E470b

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Ne pas conduire dans les 4 ou 5 heures qui suivent la prise. Consommation déconseillée sans avis médical en cas de maladie inflammatoire, auto-immune, épilepsie, asthme ou en cas de prise de traitement (antidépresseurs, somnifères ou autres sédatifs).

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List recorded in 2024. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line